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Large chromosomal DNAfragments containing different parts of the putative rubromycin polyketide synthase "gene cluster were cloned and functionally expressed in S. coelicolor CH999. Expression of these clones yielded 5-10 metabolites that were not detected in S. collinus culture extracts. This paper focusses on one of the new metabolites, termed collinone, that was isolated in large quantities and purified for spectroscopic structure determination and biological screening assays. Collinone is a heavily oxidized angular hexacyclic compound containing an unusual l ,4,5,8(2//,3//)-anthracenetetrone moiety previously only reported to be present in antibiotics SF2446A1, A2, A3, Bl and B2 isolated from Streptomyces sp. SF2446. Structure analysis of collinone indicates a tridecaketide with a 26 carbon backbone. The basic benz [a] naphthacene ring system of collinone is angular, similar to the aglycones of the wellknownangucycline and angucyclinone antibiotics. While collinone showed antibacterial activity against vancomycin-resistant enterococci, no antifungal or significant antiviral activities were detected. Collinone could be a good starting point to obtain new bioactive angucyclin(on)e-like compounds by further genetic engineering of its pathway.
Aromatic polyketides belong to a large group of structurally diverse secondary metabolites that exhibit a broad range of biological activities. More than half of the clinically important polyketides are produced in Streptomycetes via initially a commonbiosynthetic' pathway which then diverges on the specific enzymes individual species possess. Polyketide synthase (PKS) complexes catalyze the reactions which are analogous to the fatty acid synthesis, in which CoA-activated short carboxylic acids are used in repetitive decarboxylative condensations to build a polyketide chain. Structural diversity arises from a PKS encoded variability in the chain length and from the subsequent reactions such as ketoreductions, ring closures, aromatizations, hydroxylations, methylations, dimerizations, glycosylations, etc.
pp. 239 -249 Khosla and coworkers established a genetic engineering approach to generate novel, non-natural polyketides by combining the biosynthetic pathways from several organisms1 '2) .
However, this approach has several limitations:
i) owing to the substrate specificities of the enzymes involved, not all recombinant constructs will result in new metabolites; ii) the number of genes that can be recombined in a cloning system is limited to approximately 10 at the most; and iii) the existing pool of characterized pathways and sequenced genes as well as their availability are limited. To address these limitations, we isolated and partially sequenced a newpolyketide biosynthetic gene cluster from Streptomyces collinus DSM2012, a strain that makes rubromycins3 '4 The rubromycins possess numerous oxidized functionalities, some of which are methylated while others are cyclized forming a furan ring or a bicyclic acetal through the reaction of hydroxyl groups with enol functionalities in the vicinity (see Fig. 1 ). The genes of the enzymes catalyzing these chemical changes in the rubromycins were at the center of our interest in the S. collinus polyketide biosynthesis gene cluster with the aim to generate new recombinant pathways.
Here Standard medium for Streptomyces plate cultivations was R2YE; YEMEand TSB were used for liquid cultures11}. All cultivations were carried out at 30°C. Liquid cultures were incubated in a gyratory shaker (model G25, New Brunswick Scientific) at 300 rpm. Unless stated otherwise, all strains of E. coli were grown in LB medium(Bactotryptone lOg/liter, Bacto-yeast extract 5 g/liter, NaCl 5 g/liter). For solid LB, 20g/liter Bacto agar were added. E. coli strains were incubated at 37°C. Liquid cultures were incubated at 225rpm in a gyratory shaker. Antibiotics, ampicillin (100^g/ml), apramycin (20 /ig/ml in liquid and 200/ig/ml in solid medium), and tobramycin (lO^l/ml), were added as required.
Protocols for genetic manipulation of Streptomyces, isolation of DNA,and protoplast transformation were containing tobramycin (10 /il/ml) and incubated overnight at 30°C. The following day, the transductants were used to proceed to colony lifting on nylon membraneand the plates were stored at 4°C.
Colony Lifting and Southern Hybridization
The genomic library was screened by colony lifting9).
The DNA probe for detection of putative PKS genes contained the ketoacyl synthase genes for the a-and /5-subunits from the actinorhodin pathway of S. coelicolor A3 (2)12). These genes are highly conserved throughout type-II polyketide synthase genes. This fragment was isolated as a 2.6kb Pacl-Xbal fragment from pRM51). The probe was labeled for chemiluminescent detection using the containing 1%acetic acid, peaks were detected at 280 nm.
The remainder of the fractions was extracted with approximately 0.2 volume of HPLC-grade ethyl acetate. A high acetonitrile content in some fractions required the addition of distilled water until the separation of the phases occurred. Further washing of the organic phase with water was done until the pH of the aqueous phase was 5.5 to 6. The organic phase was dried, the amount of dried powder determined, and used for spectroscopic analysis, structure elucidation and biological assays. Following this procedure with MRB6Cgrown on 1.5 liter medium, 250mg collinone could be purified with a 99.9% purity. volume of acetonitrile, diluted with water and incorporated in two-fold serial dilutions into the agar. It was first verified that acetonitrile alone had no antibacterial effect at the concentrations used. Ampicillin, penicillin G and vancomycin were dissolved in water. Plates and solutions were prepared fresh daily. The inoculum was prepared from overnight cultures of strains, diluted and applied to the agar surface by using a multipoint inoculator. The size of the inoculum was about 104 colony-forming units per spot. The plates were inoculated 20 hours at 35°C. The MICs were determined as the lowest concentrations that prevented visible growth, disregarding less than 3 colonies or a faint haze.
For previously established procedures13 ' 14) . Briefly, con fluent cell cultures in microtiter 36-well plates were inoculated with 100 CCID50 of virus, 1 CCID50 being the virus dose required to infect 50%of the cell cultures. After a 1-hour virus adsorption period, residual virus was removed, and the cell cultures were incubated in the presence of varying dilutions of the test compound (80-.16^g/ml) collinone.
Viral cytopathicity was recorded as soon as it reached completion in the control virus-infected cell cultures that were not treated with the test compound.
The anti-HIV activity assays were run as described previously15). Briefly, human MT-4 (-4X 105 cells ml"1) cells were infected with 100 CCID50 of HIV-1 (IIIB) ml"1 and seeded in 200 fA wells of a microtiter plate, containing appropriate dilutions of the test compounds. After.5 days (MT-4) or 4 days (CEM) of incubation at 37°C, the number of viable (MT-4) cells was determined in a blood cell counting chamber by trypan blue dye exclusion or giant (CEM)cell formation was examined microscopically.
Results

Construction of the Recombinant Strains
The cosmid pKC505 which replicates in both Escherichia coli and Streptomyces and is capable of carrying inserts between 30 to 40kb was used to construct the S. collinus DSM2012 genomic library, resulting in 4000 clones carrying inserts of the expected size. We isolated from this library by Southern hybridization using the polyketide synthase specific actl DNAprobe, several cosmid clones that contained PKS genes. These clones could be grouped into two classes, representing two putative PKS gene clusters. DNA sequence analysis revealed that one gene cluster has strong homology to PKS genes encoding spore pigments while the other gene cluster has significant homology to the antibiotic PKS genes16).
Four cosmids, p3B, p3C, p3E, and p6C, of the latter PKS cluster, carried inserts of 30~42 kb covering about 52 kb of Culture extracts from S. collinus DSM2012 and MRB6C were analyzed by analytical HPLC (Fig. 3) . The different elution profiles of their metabolites supported the previous findings from TLC clearly showing that MRB6C produces a compound that is not present in wild type S. collinus. About 250mg of this main metabolite made by MRB6C was purified for the structural analysis and the determination of potential biological activity. Between 10-20/ig of the MRB1 metabolite were purified for structure determination.
Structure Determination
Collinone was obtained as a dark-red solid, m.p. 222~225°C. The structure of collinone (Fig. 4) was determined by NMRspectroscopy and mass spectrometry.
The latter technique showed that the molecular weight of collinone is 534, and high resolution measurements suggested that the elemental composition is C27H18O12.
This was confirmed by the presence of27 signals in the 13C NMRspectrum and signals integrating for a multiple of 18 protons in the *H NMRspectrum (ID NMRdata are given in Table 1 Culture extracts dissolved in ethyl acetate were applied onto a silicagel TLCplate and resolved with ethyl acetate/methanol 7 : 3+ 1% acetic acid. The main products in the extracts were collinone (6C-R) and 3 so for unidentified compounds (marked 3B-B, 3B-C, 3E-Y2) and putative collinomycin (col-Pl) made by S. collinus.
correlations from 19-H2 to C-21 as well as between 20-H2 to C-4, C-21 and C-22. The additional HMBCcorrelations between 20-H2 and C-18 and between 19-H2 and C-5, C-17 and C-18 show that C-19 is connected to C-18 which has C-5 and C-17 as neighbours. Both C-5 and C-18 appear from their 13C chemical shifts to be quarternary oxygenated carbons, and a weak HMBC correlation between 22-H and C-5 closes the six-membered ring adjacent to the isocoumarin system. In the other end of the molecule, HMBC correlations from the methoxy protons to C-l 1 and (weakly) to C-l2 indicate the presence of a methyl enol ether, and this is supported by the chemical shifts for the double bond carbons. 19-H gives strong HMBC correlations to C-10, C-ll and C-l4 as well as weak correlations to C-l3 and C-l5. This supports together with the observed HMBC correlations from the two remaining hydrogen bonded hydroxyl protons (from 8-OH to C-7, C-8, C-9 and (weakly) C-10, and from 15-OH to C-14, C-15, C-l6 and (weakly) C-l3) of the suggested dihydroxymethoxy-1,4-naphthoquinone substructure.
No HMBC correlations could be observed to C-6, but a very weak correlation from 19-H2 to C-l6 indicates that C-l6 is connected to either C-5 or C-17. By connecting C-l6 to C-17 and incorporating the remaining carbonyl group (C-6) into the sixth and final ring (between C-5 and C-7), the structure shown in Figure 4 was obtained. Analternative Chromatograms are shownon the left and the spectral properties of the numberedpeaks are shownon the right. The major red colored peak in the S. collinus extract (3) eluts at -30 minutes, while the major peak of MRB6C (5, collinone) elutes at 26 minutes. This peak fraction of MRB6Cwas isolated and purified for structural analysis. Peaks 2, 4 and 6 are polyketide related compounds that have not been isolated so far. As judged from the elution profile, peak 1 may not be a polyketide related substance. Separation conditions are described in detail in Materials andMethods. Fig. 4 . The structure and atom numbering of collinone.
The stereochemistry is tentatively assigned. structure, obtained by connecting C-16 to C-5 and placing C-6 between C-7 and C-17 in the last ring, is not plausible as the difference in 13C chemical shift between C-7 and C-16 would be expected to be muchlarger than that observed (2.3ppm) .
The relative stereochemistry of the C-5/C-18 bridge is suggested to be cis, based on the analysis of 90°. This condition is fulfilled in the conformation of the cis isomer having the C-6 and C-17 carbonyl groups in approximately the sameplane as the neighboring aromatic ring (as suggested by the 13C chemical shifts for C-6 and C-17), but not with the trans isomer. No attempts were made to determine the absolute stereochemistry. As indicated above, DMSO-<i6, as well as other solvents and combinations of solvents, were not suitable for NMR measurements with collinone, because the 13C NMRsignals for the dihydroxy-methoxy-l,4-naphthoquinone system could not be observed even at different temperatures. In addition, the compoundturned out to be unstable in many solvents (DMSO,acetone, methanol). This may be caused proved cytotoxic at concentrations of^16^/g/ml in various (not shown). In summary, collinone is a biologically active compound that despite its cytotoxicity also has interesting biological antibacterial activity. Current studies focus on genetic modifications of the biosynthetic pathway leading to collinone to further alter the structure in a specific way. This approach combined with a better understanding of the mode of action of collinone could lead to a more potent secondary metabolite synthesized in vivo.
Discussion
Angucycline/angucyclinone-derived secondary metabolites possess a broad spectrum of biological activities.
According to present knowledge, biosynthesis of the angucycline group of antibiotics seems to be characteristic of actinomycetes. Although the biosynthetic formation of decaketide chain is possible, for example, in the group of Fungi imperfecti, not a single 'angu'-metabolite has been found in these organisms17).
Furthermore, angucycline group metabolites have not been discovered in other natural sources17). Introduction of cosmid p6C composed of about 35kb of the putative rubromycin PKS gene cluster from S. collinus into S. coelicolor CH999 (MRB6C) resulted in the production of several compounds not detected in S. collinus. TLCanalysis of culture extracts showed that MRB6C and also MRB3C make a dark red pigmented compound named collinone which is by far the predominant compound produced by these two transformants.
The chemical structure of collinone suggests that it is an angular hexacyclic tridecaketide, with a backbone madeof 26 carbons, in which one of the keto groups has been reduced to a methylene group (C-19) molecule, it could be argued that collinone might not match the strict interpretation of the above definition. Focussing on the angular structure as the main criterion, we suggest that collinone is regarded as a member of the angucyclinone class of metabolites. To our knowledge, no structure like collinone has previously been described, and the only structures that might resemble some similarity to collinone are those of benanomicin A and B, molecules derived from a dodecaketide, an alanin, and a methionine which also fails to meet the strict criteria for an angucycline classification1 8).
A small number of reports demonstrate the feasibility to obtain an angular metabolite upon expression of a PKSin an heterologous host19~21). However, collinone is the first example of a recombinant hexacyclic angucylinone most likely derived from a tridecaketide that is synthesized in a heterologous host. In addtion, collinone is a heavily oxidized angular hexacyclic compound containing an unusual 1,4,5,8(2/ Unfortunately, only scattered information is available on the structure-function-relationship of angucylin(on)es most of which has been reviewed recently17). Most of the angucyclines/angucyclinones exhibit weak antibacterial activity, especially against Gram-positive bacteria27' 28^and, in some cases, weak antifungal activity29). More interesting are the inhibitory effect on the reverse transcriptases of the Avian myeloblastosis virus30-* and the activity against the DNAviruses Herpes simplex type 1 and 229). The majority of studies on biological activities, however, have revealed cytotoxicity/cytostatic activity of the angucyclines/angucyclinones3!~34), which might become a potential tumor treatment. Remarkably, some angucyclines (i.e. aggreticin) have been described to inhibit the growth of cell lines that are resistant to different cytostatic drugs in clinical use, e.g. doxorubicin35).
Relatively small structural differences, e.g. between a-/3-, and 7-rubromycin, result in different in biological activities including in vitro activity against Staphylococcus aureus (a-rubromycin) or the selective inhibition of HIV-1 reverse transcriptase (/3-and y-rubromycin)3~5). Collinone is structurally different from the rubromycines (Figs. 1 and  4 ) and consequently has different biological activities. Its antibacterial activity against multiresistant enterococci (vancomycin-and j84actam-resistant enterococci> Table 2) is interesting but associated with cytotoxicity; neither antifungal or significant antiviral activities were detected so far. It has been suggested that the antitumor activity of the angucyclines is due to the chromophore moiety, which in most cases, including collinone, is a hydroxyanthraquinone or a hydroxynaphtoquinone. Such activity remains to be evaluated. As expected for antitumor compounds, the activity of the angucyclines is accompanied by cytotoxicity36'37).
Considering that vancomycin is the current last line of defense for the treatment of methicillin-resistant (MRS) 
